Search Results - Karl D Lewis

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Health‐related quality of life in patients with metastatic basal cell carcinoma treated with cemiplimab: Analysis of a phase 2 trial by Ketty Peris, Timothy J. Inocencio, Alexander J. Stratigos, Karl D. Lewis, Zeynep Eroglu, Anne Lynn S. Chang, Cristina Ivanescu, Aleksandar Sekulic, Matthew G. Fury, Chieh‐I Chen, Ruben G. W. Quek

    Published in Cancer Medicine (2024-07-01)
    Get full text
    Article


  2. 2

    IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients by Richard P. Tobin, Kimberly R. Jordan, Puja Kapoor, Eric Spongberg, Dana Davis, Victoria M. Vorwald, Kasey L. Couts, Dexiang Gao, Derek E. Smith, Jessica S. W. Borgers, Jessica S. W. Borgers, Steven Robinson, Carol Amato, Rene Gonzalez, Rene Gonzalez, Karl D. Lewis, Karl D. Lewis, William A. Robinson, William A. Robinson, Virginia F. Borges, Virginia F. Borges, Virginia F. Borges, Martin D. McCarter, Martin D. McCarter

    Published in Frontiers in Oncology (2019-11-01)
    Get full text
    Article


  3. 3

    Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial by Celeste Lebbe, Omid Hamid, Shailender Bhatia, Janice M Mehnert, Patrick Terheyden, Michele Milella, Isaac Brownell, Sandra P D'Angelo, Andrew S Brohl, Kent C Shih, Karl D Lewis, Gerald P Linette, Sara Georges, Parantu Shah, Barbara Ellers-Lenz, Marcis Bajars, Gülseren Güzel, Paul T Nghiem

    Published in Journal for ImmunoTherapy of Cancer (2020-05-01)
    Get full text
    Article


  4. 4

    Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1) by Lucy Gilbert, Jameel Muzaffar, Vamsidhar Velcheti, Anna Spreafico, Emiliano Calvo, David F McDermott, Marc S Ernstoff, Valentina Boni, Karl D Lewis, Ira Winer, Olivier Dumas, Aman Chauhan, Arvind Chaudhry, Christoper J Hoimes, Seth D Rosen, Debora S Bruno, James F Strauss, Rita Dalal, Ulka N Vaishampayan, Quincy S Chu

    Published in Journal for ImmunoTherapy of Cancer (2024-11-01)
    Get full text
    Article


  5. 5

    Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence by Omid Hamid, Brendan Curti, Craig L Slingluff, Mohammed Milhem, Jose Lutzky, Suthee Rapisuwon, Brian Gastman, Takami Sato, Marcus O Butler, Robert Andtbacka, Eddy Hsueh, Robert Weber, John Glaspy, Sekwon Jang, Sajeve Thomas, Karl D Lewis, Leonel Hernandez-Aya, John Hyngstrom, Adam Berger, Edward Levine, Montaser F Shaheen, Vinay Gupta, Svetomir N Markovic, Tawnya Bowles, Joel Claveau, Prejesh Philips, Shernan G Holtan, William Schmidt, Juan Paramo, Arvinda Padmanabhan, Daniel Milton, Andrew Pecora, Suprith Badarinath, John Keech, Sujith Kalmadi, Pallavi Kumar, Anna Bar, J Thaddeus Beck, Jeffrey B Travers, Catalin Mihalcioiu, Peter Beitsch, Edward C McCarron, Deepti Behl, Brent Blumenstein, Joanna J Peterkin

    Published in Journal for ImmunoTherapy of Cancer (2021-10-01)
    Get full text
    Article


Search Tools: